LexDanaLexDanabeta
Inventor

Mark Leid

Inventor
Corvallis, OR, US

Overview

4→
Patents
2003–2011
Patent span
Chemistry
Primary field (CPC C)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07CAcyclic or carbocyclic compounds22%
C07DHeterocyclic compounds22%
C07KPeptides11%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms11%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
PatentTitleYear
8,071,815'CTIP2 expression in squamous cell carcinoma'2011RE042700'Induction of apoptosis in cancer cells'20117,053,071'Induction of apoptosis in cancer cells'20066,635,429'Heterodimeric nuclear receptors proteins, genes encoding same, and usage thereof'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003Patents assigned to BRISTOL MYERS SQUIBB CO (1)· patent assignee history
2003Patents assigned to CENTRE NAT RECH SCIENT (1)· patent assignee history
2003Based in Strasbourg, FR· patent location history
2006Patents assigned to BURNHAM INST (1)· patent assignee history
2006–2011Based in Corvallis, OR, US· patent location history
2011Patents assigned to ABECASSIS JOSEPH (1)· patent assignee history
2011Patents assigned to INDRA ARUP KUMAR (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ABECASSIS JOSEPH12011
BRISTOL MYERS SQUIBB CO12003
BURNHAM INST12006
CENTRE NAT RECH SCIENT12003
INDRA ARUP KUMAR12011
Locations
LocationPatentsSpan
Corvallis, OR, US32006–2011
Strasbourg, FR12003